Vimarsana
Biggest News Aggregation in the World

Page 18 - Sartorius News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sartorius. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sartorius Today - Breaking & Trending Today

Sartorius Stedim Q1 Profit Surges - Vimarsana News

Sartorius Stedim Q1 Profit Surges

BERLIN (dpa-AFX) - Sartorius Stedim Biotech (SARTF), a pharmaceutical and laboratory equipment supplier, on Thursday reported a significant surge in income for the first quarter, amidst a rise

Related Topics:
Stedim Biotech
Formulation QApps using a database - Vimarsana News

Formulation QApps using a database

This application note from Sartorius highlights how the Cubis ® II balance can use software programs to help create and manage formulations safely and reliably - and how to connect with a database to store results, methods and settings in a central system. 

Related Topics:
Application Note
NORTHWEST ANALYTICS AND SARTORIUS ANNOUNCE PARTNERSHIP TO DELIVER ADVANCED ANALYTICS SOLUTIONS - Vimarsana News

NORTHWEST ANALYTICS AND SARTORIUS ANNOUNCE PARTNERSHIP TO DELIVER ADVANCED ANALYTICS SOLUTIONS

Announcing a new partnership that will expand single-source, real-time analytics methodologies available to manufacturers.

Sartorius Expects 2022 Group Sales Revenue To Increase By About 15% To 19% - Vimarsana News

Sartorius Expects 2022 Group Sales Revenue To Increase By About 15% To 19%

BERLIN (dpa-AFX) - Sartorius AG (SARTF), a German pharmaceutical and laboratory equipment supplier, said it expects group sales revenue to increase by about 15 percent to 19 percent and an underlying

Related Topics:
No related topics available
Global Competition News in US and Mexico - Vimarsana News

Global Competition News in US and Mexico

FTC approved petition from Sartorius Stedim Biotech S.A. to acquire chromatography equipment business of Novasep Process SAS. Sartorius was FTC-approved, when the FTC ordered Danaher Corporation to divest assets as a condition of acquiring General Electric’s biopharmaceutical business.